Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06811389 · ClinicalTrials.gov registry record · NA
Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
A NA study of Hypersensitivity Pneumonitis, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06811389: Recruiting NA study of Hypersensitivity Pneumonitis, sponsored by Weill Medical College of Cornell University.
NCT06811389 is a NA study of Hypersensitivity Pneumonitis that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 389-participant average among 3 other Hypersensitivity Pneumonitis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06811389, a NA study of Hypersensitivity Pneumonitis, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of life (HRQOL) of patients with hypersensitivity pneumonitis (HP). The goal of this behavioral and educational intervention, RISE-HP, is to improve health-related quality of life in people who have hypersensitivity pneumonitis and assess feasibility and accessibility of this intervention. Patients with hypersensitivity pneumonitis (HP) experience uncertainty, feelings of anxiety and depression, and marked disruption to their lifestyle and home environment. Poor health-related quality of life (HRQOL) in HP is also driven in part by patients' profound lack of knowledge about the disease. Existing interventions for patients with HP do not target improvement in quality of life. Participants will complete either RISE-HP, a 10-session peer coach delivered behavioral and educational intervention to improve HRQOL in HP, or Staying Well, a 10-session general health education program.
Conditions Studied
Interventions
- BEHAVIORAL Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP)
- BEHAVIORAL Staying Well
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-05-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06811389 shows while recruiting
NCT06811389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 389-participant average among 3 other Hypersensitivity Pneumonitis trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Hypersensitivity Pneumonitis appearing as the primary indexed condition, and to 2 interventions - of which Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP) is the first listed.
NCT06811389 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06811389 about?
NCT06811389 is a clinical study titled "Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis". The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of life (HRQOL) of patients with hypersensitivity pneumonitis (HP). The goal of this behavioral and educa...
What is the current status of trial NCT06811389?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-05-06. Estimated completion is 2026-12.
What conditions does trial NCT06811389 study?
This clinical trial studies the following conditions: Hypersensitivity Pneumonitis.
What interventions are being tested in trial NCT06811389?
The interventions under investigation include: Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP) (BEHAVIORAL), Staying Well (BEHAVIORAL).
Who is sponsoring clinical trial NCT06811389?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06811389 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity Pneumonitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI